Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

Clinical trial NCT03579446 · TERMINATED

Trial details

NCT number: NCT03579446
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm

Start date: 2018-11-29
Primary completion: 2023-06-15
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.